SHS and KfW are participating in a capital increase in the Warngau (AMW) pharmaceutical plants. AMW develops and produces agents for controlled drug administration via the skin, such as special active ingredient patches. The founder is Wilfried Fischer, who also founded Novosis. With its growth capital, AMW intends to develop its products to market maturity and market them internationally. The level of commitment is unknown.